Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Clear Genetics
AddedMar 17, 2024
UpdatedJul 3, 2026
Clear Genetics

Clear Genetics

Acquired

Clear Genetics: Scaling genomic services with innovative software.

Founded
2016
Accelerator
Y Combinator logoY CombinatorW17
Overview
Compare
Fundraising
Employees

Clear Genetics is dedicated to integrating genetics into routine patient care through innovative, patient-centric software. Their HIPAA-compliant platform, including the virtual Genetic Information Assistant (Gia), automates the delivery of genetic services at scale. Clear Genetics serves leading health systems, clinics, and commercial labs across the nation, facilitating virtual conversations with patients and streamlining the intake of personal and family history.

Clear Genetics has made significant strides in scaling genomic services, impacting the healthcare industry by making genetic testing more accessible and efficient. Their platform's automation capabilities have enhanced the ability of healthcare providers to deliver comprehensive genetic services, improving patient outcomes and operational efficiency.

Clear Genetics - Similar Companies

Nest Genomics logo

Nest Genomics

nestgenomics.com

Probably Genetic logo

Probably Genetic

Haplotype Labs logo

Haplotype Labs

haplotypelabs.com

Genome Medical logo

Genome Medical

genomemedical.com

GenomeNext logo

GenomeNext

ThinkGenetic logo

ThinkGenetic

thinkgenetic.com

Emedgene logo

Emedgene

emedgene.com

Gencove logo

Gencove

gencove.com

Gradia Health logo

Gradia Health

gradia.com

Geneticure logo

Geneticure

geneticure.com

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Fit Genetics logo

Fit Genetics

Clear Gene logo

Clear Gene

cleargene.com

My Gene Counsel logo

My Gene Counsel

mygenecounsel.com

Allelica logo

Allelica

allelica.com

Clear Genetics - Quick Facts

Who are Clear Genetics' competitors?

Companies similar to Clear Genetics include Nest Genomics, Probably Genetic, Haplotype Labs and Genome Medical.

When was Clear Genetics founded?

Clear Genetics was founded in 2016.

When was Clear Genetics' last funding round?

Clear Genetics' most recent funding round was for $120k (USD) in January 2017.

How much has Clear Genetics raised to-date?

As of Jan 1, 2017, Clear Genetics has raised a total of $120k (USD).

Clear Genetics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
  • Usage-based
Customer
  • Enterprise
Main Product
  • Genetic Services
  • Software
Tags
  • Chatbot
  • Healthcare
  • Healthtech